-

FUJIFILM Irvine Scientific Launches Heavy Oil for Embryo Culture: Optimized Protection for the IVF Laboratory

Offering ideal handling viscosity with added confidence from rigorous testing procedures

SANTA ANA, Calif.--(BUSINESS WIRE)--FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell culture media and assisted reproductive technologies (ART), today announced the launch of its Heavy Oil for Embryo Culture, a sterile mineral oil with an optimal weight viscosity that provides the ideal balance between ease of use and protection.

Common concerns within the IVF Laboratory for embryo development during in vitro culture include media evaporation, changes in osmolality, and pH shifts due to the small volume of media used. Heavy Oil for Embryo Culture addresses those concerns with the ideal viscosity to provide an optimal in vitro environment for embryo development. To ensure the utmost quality, each raw material lot of Heavy Oil for Embryo Culture is validated using FUJIFILM Irvine Scientific’s genetic mouse embryo assay MEGA, a bioassay with increased sensitivity for detecting embryotoxic materials when compared to traditional mouse embryo assays (MEA). Every lot of oil produced also undergoes rigorous quality testing procedures for sterility, endotoxin presence, human sperm survival, MEA, and peroxide values—all reported on the Certificates of Analysis for transparency.

"FUJIFILM Irvine Scientific continues to be the leader in providing innovative technologies in IVF with the goal of helping to build families," said Steven Geimer, executive director of the medical business unit, FUJIFILM Irvine Scientific, Inc. "The addition of Heavy Oil for Embryo Culture to our portfolio gives customers the option to choose the viscosity that best suits their protocols and preferences. Heavy Oil for Embryo Culture is designed to provide the extra blanket of protection and stability needed to ensure the safest possible culture environment for developing embryos.”

Heavy Oil for Embryo Culture is approved for sale immediately in the USA, Japan, Korea, and Hong Kong. For more information about this product, including additional territory availability, contact us or visit https://www.irvinesci.com/assisted-reproductive-technology.

ENDS

Contacts

Lily Jeffery
Zyme Communications
Phone: +44 (0)7891 477 378
Email: lily.jeffery@zymecommunications.com

FUJIFILM Irvine Scientific, Inc.


Release Versions

Contacts

Lily Jeffery
Zyme Communications
Phone: +44 (0)7891 477 378
Email: lily.jeffery@zymecommunications.com

More News From FUJIFILM Irvine Scientific, Inc.

CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing

KAWASAKI, Japan & SANTA ANA, Calif.--(BUSINESS WIRE)--Chitose Laboratory Corp., (CHITOSE), a leading company of the bioeconomy and provider of advanced cell line development services, and FUJIFILM Biosciences Inc., a global leader in the innovation and manufacture of cell culture solutions for the life science market, today announced a new strategic alliance that leverages the strengths of both companies in advancing biopharmaceutical production. CHITOSE’s expertise in cell line development usi...

FUJIFILM Biosciences Introduces BalanCD HEK293 Perfusion A Medium to Enable Gene Therapy Production

SANTA ANA, Calif.--(BUSINESS WIRE)--FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A. Designed to expand and augment the company’s portfolio of gene therapy application solutions, BalanCD HEK293 Perfusion A uses suspension HEK293 cells and perfusion technology to provide reliable, efficient, and scalable production of viral vectors for development of...

Fujifilm Rebrands Life Sciences Companies to Strengthen Position as Strategic Partners for Life, Offering End-to-End Solutions

TOKYO--(BUSINESS WIRE)--FUJIFILM Corporation's Life Sciences Group companies, a portfolio of businesses offering products, services and comprehensive solutions that span all stages of therapeutic development from discovery through to commercialization, today announced new names and identities as part of a strategic positioning effort. The Group Companies’ new names, collaborative strategic focus, and structural alignment reflects Fujifilm’s commitment to Life Sciences, offering fully integrated...
Back to Newsroom